A groundbreaking study reveals that combining the Mediterranean diet with calorie reduction and exercise can reduce the risk of Type 2 diabetes by 31%. Learn how these lifestyle changes can transform your health!
A groundbreaking study reveals that adopting a Mediterranean diet, reducing calories, and engaging in moderate exercise can lower type 2 diabetes risk by 31%. Discover how simple lifestyle changes can save millions from this global epidemic.
Lilly's new oral pill, Orforglipron, has shown promising results in reducing weight and improving blood sugar levels in diabetes patients. With nearly 4% rise in shares, the drug is on track for FDA approval.
A new retrospective study indicates that while GLP-1 receptor agonists for diabetes may slightly increase the risk of new-onset diabetic retinopathy, they also significantly reduce the risk of vision loss. Experts emphasize the importance of regular eye examinations for patients.
A groundbreaking study shows that aiming for 7,000 steps a day can significantly improve health outcomes, nearly matching the benefits of the traditional 10,000-step goal. Discover the new benchmark for daily movement.
Discover the crucial role of diet and exercise alongside GLP-1 medications for effective weight loss. Experts reveal tips to maximize benefits and minimize side effects.
A groundbreaking study reveals there's no safe level of processed meat consumption, linking even small amounts to increased risks of serious health issues like diabetes and cancer. Find out why cutting back is crucial for your health!
Research reveals that over 15 million people in the US, UK, Germany, and France are unaware they have metabolic dysfunction-associated steatotic liver disease, a condition linked to severe health risks. Experts call for increased screenings and diagnosis rates.
A groundbreaking study shows that GLP-1 diabetes drugs may reduce the risk of obesity-related cancers by 7% compared to DPP-4 inhibitors, particularly in women. Discover the implications for diabetes treatment!
New research reveals that silencing hyperactive AgRP neurons in the brain could reverse type 2 diabetes without affecting weight or diet. This groundbreaking study challenges existing beliefs and points to new treatment avenues.
